{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T09:29:33Z","timestamp":1794475773390,"version":"4.9.1"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000016","name":"U.S. Department of Health and Human Services","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000016","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["75N93019C00052"],"award-info":[{"award-number":["75N93019C00052"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.vaccine.2026.128674","type":"journal-article","created":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T13:59:09Z","timestamp":1778248749000},"page":"128674","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Retooling a novel influenza B hemagglutinin to redirect neutralizing antibodies against B\/Victoria strains"],"prefix":"10.1016","volume":"84","author":[{"given":"Michael A.","family":"Carlock","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ted M.","family":"Ross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.vaccine.2026.128674_bb0005","doi-asserted-by":"crossref","first-page":"81","DOI":"10.4161\/hv.8.1.17623","article-title":"The rationale for quadrivalent influenza vaccines","volume":"8","author":"Ambrose","year":"2012","journal-title":"Hum Vaccin Immunother"},{"issue":"2392","key":"10.1016\/j.vaccine.2026.128674_bb0010","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1126\/science.92.2392.405","article-title":"A new type of virus from epidemic influenza","volume":"92","author":"Francis","year":"1940","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.vaccine.2026.128674_bb0015","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1038\/s41467-022-29402-5","article-title":"Human seasonal influenza under COVID-19 and the potential consequences of influenza lineage elimination","volume":"13","author":"Dhanasekaran","year":"2022","journal-title":"Nat Commun"},{"issue":"12","key":"10.1016\/j.vaccine.2026.128674_bb0020","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1038\/s41579-021-00642-4","article-title":"Influenza lineage extinction during the COVID-19 pandemic?","volume":"19","author":"Koutsakos","year":"2021","journal-title":"Nat Rev Microbiol"},{"issue":"39","key":"10.1016\/j.vaccine.2026.128674_bb0025","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2022.27.39.2200753","article-title":"Has influenza B\/Yamagata become extinct and what implications might this have for quadrivalent influenza vaccines?","volume":"27","author":"Paget","year":"2022","journal-title":"Euro Surveill"},{"key":"10.1016\/j.vaccine.2026.128674_bb0030","series-title":"FluView interactive 2025 March 8","author":"Center for Disease Control and Prevention, N.C.Ff.I.Aa.R.D.N","year":"2025"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2026.128674_bb0035","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.virol.2013.07.035","article-title":"Structural basis for the divergent evolution of influenza B virus hemagglutinin","volume":"446","author":"Ni","year":"2013","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2026.128674_bb0040","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1073\/pnas.1916585116","article-title":"Divergent evolutionary trajectories of influenza B viruses underlie their contemporaneous epidemic activity","volume":"117","author":"Virk","year":"2019","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.vaccine.2026.128674_bb0045","series-title":"Influenza virus characterization: summary report, Europe, February 2023, W.H.O.W.a.t.E.C.f.D.P.a.C. (ECDC), Editor","author":"Region","year":"2023"},{"issue":"23","key":"10.1016\/j.vaccine.2026.128674_bb0050","doi-asserted-by":"crossref","first-page":"4121","DOI":"10.1093\/bioinformatics\/bty407","article-title":"Nextstrain: real-time tracking of pathogen evolution","volume":"34","author":"Hadfield","year":"2018","journal-title":"Bioinformatics"},{"issue":"43","key":"10.1016\/j.vaccine.2026.128674_bb0055","doi-asserted-by":"crossref","first-page":"16874","DOI":"10.1073\/pnas.0708363104","article-title":"Structural basis for receptor specificity of influenza B virus hemagglutinin","volume":"104","author":"Wang","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"10.1016\/j.vaccine.2026.128674_bb0060","doi-asserted-by":"crossref","first-page":"3011","DOI":"10.1128\/JVI.02477-07","article-title":"Crystal structure of unliganded influenza B virus hemagglutinin","volume":"82","author":"Wang","year":"2008","journal-title":"J Virol"},{"issue":"10","key":"10.1016\/j.vaccine.2026.128674_bb0065","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1002\/jmr.2293","article-title":"The specificity of the influenza B virus hemagglutinin receptor binding pocket: what does it bind to?","volume":"26","author":"Velkov","year":"2013","journal-title":"J Mol Recognit"},{"key":"10.1016\/j.vaccine.2026.128674_bb0070","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.virol.2013.11.038","article-title":"The roles of hemagglutinin Phe-95 in receptor binding and pathogenicity of influenza B virus","volume":"450-451","author":"Ni","year":"2014","journal-title":"Virology"},{"issue":"9","key":"10.1016\/j.vaccine.2026.128674_bb0075","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.3390\/v16091356","article-title":"Influenza B virus receptor specificity: closing the gap between binding and tropism","volume":"16","author":"Page","year":"2024","journal-title":"Viruses"},{"key":"10.1016\/j.vaccine.2026.128674_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.virusres.2025.199598","article-title":"Characterization of antigenically dominant regions in the hemagglutinin protein of B\/Victoria-lineage influenza B virus using monoclonal antibody escape mutants","volume":"358","author":"Matsuzaki","year":"2025","journal-title":"Virus Res"},{"issue":"42","key":"10.1016\/j.vaccine.2026.128674_bb0085","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2211616119","article-title":"Substitutions near the HA receptor binding site explain the origin and major antigenic change of the B\/Victoria and B\/Yamagata lineages","volume":"119","author":"Rosu","year":"2022","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.vaccine.2026.128674_bb0090","doi-asserted-by":"crossref","first-page":"15911","DOI":"10.1038\/s41598-023-43003-2","article-title":"A computationally optimized broadly reactive hemagglutinin vaccine elicits neutralizing antibodies against influenza B viruses from both lineages","volume":"13","author":"Carlock","year":"2023","journal-title":"Sci Rep"},{"issue":"0","key":"10.1016\/j.vaccine.2026.128674_bb0095","article-title":"Breadth of antibody activity elicited by an influenza B hemagglutinin vaccine is influenced by pre-existing immune responses to influenza B viruses","volume":"0","author":"Carlock","year":"2025","journal-title":"J Virol"},{"issue":"3","key":"10.1016\/j.vaccine.2026.128674_bb0100","article-title":"High-yield expression and purification of recombinant influenza virus proteins from stably-transfected mammalian cell lines","volume":"8","author":"Ecker","year":"2020","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.vaccine.2026.128674_bb0105","series-title":"Manual for the laboratory diagnosis and virological surveillance of influenza","author":"Network, W.G.I.S","year":"2011"},{"issue":"9","key":"10.1016\/j.vaccine.2026.128674_bb0110","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1080\/21645515.2019.1642056","article-title":"Impact of age and pre-existing immunity on the induction of human antibody responses against influenza B viruses","volume":"15","author":"Carlock","year":"2019","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2026.128674_bb0115","series-title":"Guideline on influenza vaccines: non-clinical and clinical module (draft)","author":"Agency, E.M","year":"2014"},{"issue":"1","key":"10.1016\/j.vaccine.2026.128674_bb0120","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1002\/jmv.21335","article-title":"Diversifying selective pressure on influenza B virus hemagglutinin","volume":"81","author":"Shen","year":"2009","journal-title":"J Med Virol"},{"issue":"13","key":"10.1016\/j.vaccine.2026.128674_bb0125","doi-asserted-by":"crossref","first-page":"3812","DOI":"10.1093\/nar\/gkg509","article-title":"SIFT: predicting amino acid changes that affect protein function","volume":"31","author":"Ng","year":"2003","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.vaccine.2026.128674_bb0130","series-title":"Biochemistry","author":"Berg","year":"2015"},{"issue":"3","key":"10.1016\/j.vaccine.2026.128674_bb0135","doi-asserted-by":"crossref","DOI":"10.1002\/wcms.1448","article-title":"Computational prediction of protein\u2013protein binding affinities","volume":"10","author":"Siebenmorgen","year":"2020","journal-title":"WIREs Computational Molecular Science"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26004822?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26004822?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T09:01:04Z","timestamp":1794474064000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X26004822"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":27,"alternative-id":["S0264410X26004822"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.128674","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Retooling a novel influenza B hemagglutinin to redirect neutralizing antibodies against B\/Victoria strains","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.128674","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"128674"}}